药械组合产品中提取物和浸出物的毒理学风险评估

来源 :医药包装与药物给药系统国际峰会 | 被引量 : 0次 | 上传用户:fugaowen
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
  Therapies targeting activated oncogenes of human tumour cells have been associated with several successes in the last decades and will be presented and disc
会议
会议
会议
  Although liver transplantation is an accepted form of treatment for selected patients with hepatocellular cancer (HCC),it is also performed in patients with
会议
会议
会议
  Aim.To detect the expression of dual oxidase (DUOX) 2 in Barrett esophagus,gastric cancer,and colorectal cancer (CRC).Materials and Methods.Tissue samples w
会议
会议
  The main limitations of current companion diagnostics (Cdx) are a) multiplicity of drugs that require a large number of tests (and different technologies) t
会议
会议